Drug profile · INN
bromfenac sodium
BROMFENAC SODIUM
bromfenac sodium (BROMFENAC SODIUM) is a cyclooxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — bromfenac sodium
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
bromfenac sodium (BROMFENAC SODIUM) is a cyclooxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is bromfenac sodium?
bromfenac sodium (BROMFENAC SODIUM) is a cyclooxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for bromfenac sodium?
BROMFENAC SODIUM is a marketed brand name for bromfenac sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bromfenac sodium?
bromfenac sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.